"Designing Growth Strategies is in our DNA"

Macular Edema Treatment Market Size, Share and Global Trend By Type (Diabetic Macular Edema, Cystoid Macular Edema), By Treatment Type (Anti-VEGF (Vascular Endothelial Growth Factor) Injections, Anti-inflammatory Medications, Corticosteroids), By End User (Hospitals, Ophthalmic Care Institutions, Ambulatory Surgery Centres) and Geography Forecast till 2021-2028

In July 2018, ThromboGenics, Belgium based biotechnology company completed its first clinical trial of an antibody (THR-317) for the treatment of macular edema. Macular e... Read More

Final report will be updated to address the impact of COVID-19 on this particular market

Region : Global | Published Date: Upcoming | Report ID: FBI101152 | Status : Upcoming

 

Request PDF Brochure

Refresh Button
Macular Edema Treatment Market Size, Share and Global Industry Trend Forecast till 2025
  • PDF
  • 2018
  • 2014-2018
  • Direct Purchase
  • 4850
    6850
    8850

Healthcare Clients

3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
Jubilant
Lek
Pfizer
Roche
Siemens Healthineers
Styker
uniliver


We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info.
X